Illumina’s Reliable Robust Solutions: Tony Gordon | Illumina Video

3 March 2015

Tony Gordon, Genesis Genomics Managing Director (US) and Lab Director (UK) discusses why he chooses Illumina technology for NIPT, PGS, and PGD. Learn more about how next-generation sequencing (NGS) is advancing reproductive genetic health http://clinical.illumina.com/clinical/reproductive-genetic- health.html?sciid=2014243IBN1.

Share this article on